PLx Pharma Inc expected to post a loss of 22 cents a share - Earnings Preview

PLx Pharma Winddown

04/08/2021 14:08

* PLx Pharma Inc  PLXP.OQ   PLXP.O  is expected to show a fall
in quarterly revenue when it reports results on August 6. 
​* Refinitiv's mean analyst estimate for PLx Pharma Inc is for a
loss of 22 cents per share. For the same quarter last year, the
company reported a loss of 66 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for PLx Pharma Inc
is $21.5​, about 14.4% above​ its last closing price
of $18.41. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.21       -0.21      -0.73     Missed  -242.2
 Dec. 31 2020  -0.29       -0.29      -0.87     Missed  -200
 Sep. 30 2020  -0.42       -0.42      -0.40     Beat    5.9​
 Jun. 30 2020  -0.41       -0.41      -0.66     Missed  -59
 Mar.          -0.40​      -0.39      0.08      Beat    120.3​
 31​ 2020​                                              
 Dec. 31 2019              -0.48      -0.25     Beat    47.9​
 Sep. 30 2019  -0.50       -0.49      0.09      Beat    118.2
 Jun. 30 2019  -0.43       -0.43      -1.10     Missed  -152.9
 This summary was machine generated August 4 at 13:08 GMT.  All
figures in US dollars unless otherwise stated